MGB Radiology Launches Clinical Validation of Crescom MSK AI

Mass General Brigham Radiology has begun clinical validation of an AI tool for musculoskeletal imaging developed by Crescom. No performance metrics or clinical outcomes have been reported yet; the validation is ongoing.

• Mass General Brigham (MGB) Radiology announced the start of clinical validation for Crescom's musculoskeletal AI algorithm.
• No results or performance data are available as the validation is just commencing.
• This is an early-stage evaluation; the tool's real-world utility remains unproven.

RadPigeon summaries are original and for information only. They are not clinical advice.